Defibtech
Allison Bohren, MS, CCRP, currently serves as the Manager of Regulatory Affairs at Defibtech, LLC, a position held since October 2020, after progressing from Senior Regulatory Affairs Specialist. Prior experience includes roles such as Assistant Director of Regulatory Affairs at Yale Cancer Center and Senior Manager of Global Regulatory Affairs at Vertex Pharmaceuticals and EMD Serono, Inc. Allison has also held managerial and specialist roles in various organizations, including Infinity Pharmaceuticals, Millennium Pharmaceuticals, and Genzyme. Educational qualifications include a Master of Science in Regulatory Affairs from Northeastern University and a Bachelor of Science in Molecular and Cell Biology and Psychology from the University of Connecticut.
This person is not in any teams
Defibtech
2 followers
Defibtech, LLC, is a leader and innovator in the design and manufacture of automated external defibrillators (AEDs) and other lifesaving resuscitation products such as the new automated chest compression device Lifeline ARM. By using advanced design and manufacturing techniques, Defibtech provides value-oriented, easy-to-use solutions with high quality and reliability. Defibtech devices include the Lifeline™ and ReviveR™ families of AEDs and related accessories. With more than 450,000 defibrillators shipped worldwide in various language configurations, Defibtech has drawn accolades and won numerous awards for innovative product design, growth, quality, and services. Defibtech’s products are sold exclusively through their network of distribution partners in the United States and in more than 50 countries around the world. With headquarters in Guilford, Conn., Defibtech designs and manufactures its products in the United States according to current Good Manufacturing Practices in state-of-the-art ISO compliant facilities.